Transcriptional regulation of the S-layer protein type I secretion system in Caulobacter crescentus by Toporowski, Michael C. et al.
www.fems-microbiology.org
FEMS Microbiology Letters 251 (2005) 29–36Transcriptional regulation of the S-layer protein type I
secretion system in Caulobacter crescentus
Michael C. Toporowski a, John F. Nomellini a, Peter Awram a, Assaf Levi b, John Smit a,*
a University of British Columbia, Department of Microbiology and Immunology, Vancouver, B.C. Canada V6T 1Z3
b University of Basel, Division of Molecular Microbiology, Basel, Switzerland
Received 2 June 2005; received in revised form 18 July 2005; accepted 19 July 2005
First published online 8 August 2005
Edited by M. SchembriAbstract
The Gram-negative Caulobacter crescentus exports RsaA, the crystalline S-layer subunit protein using a dedicated type I secre-
tion system. The protein and two transporter genes (rsaADE) are located together, comparable to the Escherichia coli type I hem-
olysin hlyCABD operon, where read through of a stem loop following hlyCA results in reduced transcription of the hlyBD. Using
two genetic approaches and a direct assessment of transcription from regions 5 0 to the genes we learned that rsaD and rsaE were
transcribed together as a separate transcript from rsaA. These results are contrary to previous assumptions about the rsaADE type I
secretion gene control and add another theme to the area of type I secretion transcription regulation. It may be that to accommodate
the high levels of RsaA secretion, the type I transporters must be transcribed independently from rsaA.
 2005 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
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Gram negative type I secretion is a Sec-independent
process which transports protein from the cytoplasm
to the exterior of the cell without periplasm contact. It
is composed of a three-component ATP-binding-cas-
sette (ABC) based exporter containing an ABC trans-
porter, membrane fusion protein (MFP) and outer
membrane protein (OMP). In most type I systems the
ABC transporter and MFP genes are adjacent to the se-
creted protein gene, whereas the OMP gene location can
vary. In some cases, the genes for all three transport
components are immediately adjacent to the substrate
gene [1–3]. In others only the ABC-transporter and0378-1097/$22.00  2005 Federation of European Microbiological Societies
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richia coli TolC and the Caulobacter crescentus RsaFa
and RsaFb OMP genes are distant from the other com-
ponents [6].
Transcriptional regulation of the type I components
has not been extensively studied. Until recently
transcriptional regulation of type I systems was only
described for the HlyA system of E. coli. where co-
transcription of the transporter genes has been demon-
strated [7]. Transcription of the four diﬀerent genes in
the hlyCABD operon was shown using gene probes for
hlyCA as well as hlyB and hlyD. Two mRNA tran-
scripts, estimated at 4 and 8 kb, corresponding to tran-
scripts containing the hlyCA genes and the hlyCABD
genes. It was concluded that hlyB and hlyD are tran-
scribed using the hlyCA promoter by read through of
a q-independent terminator between the hlyA and hlyB
genes.. Published by Elsevier B.V. All rights reserved.
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the transcriptional regulation of type I systems is
becoming more divergent. Two type I systems have been
found to have separate promoters for the transported
protein as well as the transporter components. The
Campylobacter fetus (SapA) and Serratia marcescens
(Lip) systems have separate promoters for the S-layer
(or S-layer like) gene and the transporter genes [2,8].
The sapDEF genes are transcribed in the opposite direc-
tion from the sapA gene. The lipBCD genes are located
immediately downstream of the slaA gene with a sepa-
rate promoter for the lipBCD gene set. In Serratia lique-
faciens the Lip type I transporter mediates transport of a
lipase, metalloprotease and an S-layer protein and tran-
scriptional control of the transporter is separate from
that of the S-layer protein [9].
In C. crescentus, the S-layer monomer (encoded by
rsaA) is also secreted by a type I secretion system
and does so at high levels (approximately 10–12% of
total cell protein). The promoter for rsaA was identi-
ﬁed when the S-layer protein was initially character-
ized [10]. The genes encoding the ABC transporter
(rsaD) and the membrane fusion protein (rsaE) were
identiﬁed adjacent to the rsaA gene by Tn5 insertional
inactivation [11]. Two OMPs were later found else-
where [6]. The rsaA gene has a moderate strength pro-
moter and has been used in gene expression studies as
a reference gene [12] since rsaA is transcribed through-
out the cell cycle [13]. A putative rho-independent ter-
minator is found 40 bp 3 0 of the rsaA translational
stop, which is located 162 bp 5 0 of the rsaD start co-
don. As no additional promoter sequences were imme-
diately obvious in the DNA sequence of the rsaADE
cluster upon its discovery, it was presumed that the
rsaA promoter occasionally read through the rho-inde-
pendent terminator, allowing for the transcription of
rsaD and rsaE, in a manner comparable to the
E. coli HlyA system [7].
However, the high secretion levels of RsaA raised the
question of whether such a low level transcription strat-
egy would be capable of sustaining adequate levels of
transporter components. One reason for additional
investigation is that the C. crescentus S-layer secretion
system has been adapted for recombinant protein secre-
tion and remains as one of few alternatives to secretion
of heterologous proteins by systems using sec-dependant
pathways [14]. The expression system functions by fus-
ing a heterologous segment to the rsaA C-terminal secre-
tion signal. Thus if rsaA, D and E are transcribed as a
single mRNA transcript, then the features (such as sta-
bility) of the heterologous mRNA would also directly
aﬀect transporter expression and could adversely impact
secretion. To determine transcription of the transporter
genes two genetic approaches were used to demonstrate
that rsaD and rsaE are co-transcribed using a promoter
distinct from the rsaA promoter. In addition, the pro-moter regions of rsaD and E were cloned and transcrip-
tion assessed by a reporter assay.2. Materials and methods
2.1. Bacterial strains, plasmids, and growth conditions
E. coli DH5a or DH10B (Invitrogen Corp., Carlsbad,
CA) were used for all DNA manipulations, except when
a non-methylated ClaI site was required, and then strain
RB404 was used. E. coli was grown at 37 C in Luria
broth (1% tryptone, 0.5% NaCl, 0.5% yeast extract) with
1.3% agar for plates. C. crescentus CB15 strains were
grown at 30 C in PYE medium (0.2% peptone, 0.1%
yeast extract, 0.01% CaCl2, 0.02% MgSO4) with 1.2%
agar for plates. In E. coli ampicillin (Ap) was used at
50 lg/ml, kanamycin (Km) at 50 lg/ml, chlorampheni-
col (Cm) at 20 lg/ml, streptomycin (Sm) at 50 lg/ml
and tetracycline (Tet) at 20 lg/ml. In C. crescentus Km
was used at 25 lg/ml, Cm at 2 lg/ml, Sm at 10 lg/ml
and Tet at 10 lg/ml.
2.2. Plasmid and DNA manipulations
Standard methods of DNA manipulation and isola-
tion were used [15]. Electroporation of C. crescentus
was performed as described [16]. PCR products were
generated using Platinum Pfx DNA polymerase (Invit-
rogen) following the manufacturers protocols. Chromo-
somal DNA from C. crescentus strain NA1000 was used
as template for the rsaD and rsaE PCR products. C.
crescentus CB15 chromosomal DNA was used for rsaA
deletion PCR products.
A fragment containing the rsaD gene was ampliﬁed
by PCR using the primers 5 0-CCGAATTCCATGTTC-
AAGCGCAGC-3 0 and 5 0-GCGGCCGCTCTGGAC-
GCGCTGCAA-3 0 incorporating EcoRI and NotI
restriction sites. This gene fragment was inserted into
the EcoRV site of the pBSKSI+ plasmid. The pBSKSI+:
rsaD plasmid was cut with EcoRI and NotI releasing the
rsaD fragment. This fragment was inserted into EcoRI-
NotI cut pGEX4T3 plasmid. The pGEX4T3: rsaD con-
struct is an in-frame insertion of the rsaD gene so that it
contains a C-terminal GST tag.
Another fragment containing the rsaE gene was
ampliﬁed by PCR using the primers 5 0-CCGAATTC-
CATGAAGCCCCCCAAG-3 0 and 5 0-GCGGCCGCT-
CTCCTCGCGCATCGT-3 0 and cloned into pGEX4T3
in a similar manner as the rsaD gene.
The plasmid pAL1 was constructed in order to create
an in-frame deletion of the complete rsaA coding region.
A PCR product encoding a 1.0 kb region upstream
of the rsaA gene was ampliﬁed using the primers
50-GGATCCGGCGTTCGAGCTGCTGCTGA-30 and
50-GAATTCTCACCTGGCGGGTGAGTGAG-30 intro-
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was created using the primers 5 0-GAAATTCCGCTC -
GCCTAAGCGAACGTC-3 0 and 5 0-ACTAGTGGCC-
GAGATCTTGCCGTCGA-3 0 amplifying a 1.0 kb
region containing the end of the rsaA gene and incorpo-
rating EcoRI and SpeI sites. Fragments were digested
with EcoRI, BamHI and SpeI, and ligated into BamHI
and SpeI cut pNPTS138 plasmid [17] using the pGEM-
T Easy kit (Promega). This resulted in pAL1 which was
transformed into E. coli by electroporation.
The pUC19 RAT1 plasmid was made by removing
the insert from pRAT1 [11] as an EcoRI–SstI fragment
and inserting the fragement into EcoRI and SstI di-
gested pUC19. Interruption of the rsaA gene in the
pUC19 RAT1 construct was done with the omega anti-
biotic resistance cassette, XCm, from pHP45XCm [18].
The XCm cassette was removed as a BamHI fragment
and blunted with T4 polymerase. pUC19 RAT1 was di-
gested with ClaI and blunted. The blunted XCm cassette
was ligated into pUC19 RAT1 resulting in pUC19
RAT1 XCm, in order to make a broad host range con-
struct containing the RAT1XCm fragment. The EcoRI–
SstI RAT1XCm fragment from pUC19 RAT1XCm was
ligated into EcoRI–SstI digested pBBR4, creating
pBBR4 RAT1XCm.
To clone and assess potential promoter regions of
rsaD and rsaE pXCA601 was selected. This is a broad
host range plasmid containing a promoter-less but
otherwise complete b-galactosidase gene, with Tet resis-
tance as a selectable marker [19]. The rsaD promoter re-
gion selected began 85 bp 3 0 of the rsaA stop codon, did
not include the putative rho-independent terminator of
rsaA and terminated with sequence corresponding to
the ﬁrst nine amino acids of RsaD, which were fused
to the position corresponding to the fourth amino acid
of b-galactosidase. Similarly, the selected rsaE promoter
region began immediately after the rsaD stop codon, in-
cluded the sequence corresponding to the ﬁrst nine ami-
no acids of RsaE and was joined to the fourth amino
acid of b-galactosidase. To accomplish this the oligos
JNRDP-1 5 0TGCATGCATGCGCTACGCGCTGGC-
CGGCCTTGC 3 0 and JNRDP-2 – 5 0GAGATCTCCC-
GGCTTCGCGCCGCTGCGCTTGAACAT 3 0 and the
oligos JNREP-3 5 0TGCATGCATCCGGGGCTG-
CGCCGCCCCAGACGC 3 0 and JNREP-45 0GAGAT-
CTCCCGGACGCTGGATCTTGGGGGGCTTCAT3 0
were used to PCR amplify the potential promoter re-
gions of rsaD and rsaE, respectively. Nsi1 and Bgl11
restriction sites are underlined. Two microliter of C.
crescentus cell culture were directly used as the DNA
template source for PCR ampliﬁcation with Pfx poly-
merase. The PCR product ﬁdelity was conﬁrmed by
sequencing. The PCR product was then digested with
Nsi1 and Bgl11, ligated into the Pst1 and BamH1 sites
of pXCA601 and transformed into E. coli, and subse-
quently C. crescentus, by electroporation.2.3. RsaADE gene transcription
A CB15 strain with a deleted rsaA gene was created
using the pAL1 plasmid by conjugation with the
E. coli LS980 (match maker) and MT607 helper strains
(D. Alley). The helper strain utilizes the vector pRK600,
a derivative of pRK2013, Cmr, containing the Tn9 inser-
tion, ColE1 ori, and tra functions from pRK2013 [20].
Homologous recombination was conﬁrmed by PCR
analysis (not shown) and the resulting CB15 was desig-
nated UJ2602.
The CB15A Tn5 mutant B15 was previously de-
scribed [11]. The pBBR4: RAT1XCm plasmid was
transformed into the B15 strain by electroporation and
cells were selected for resistance to Km, Cm, and Sm.
2.4. Investigating promoter activity of rsaD and rsaE
Amodiﬁed, standard b-galactosidase activity assay of
the promoter constructs was performed [21]. Cultures of
C. crescentus containing the promoter probe constructs
were grown in PYE and normalized to the same
OD600nm (0.3–0.4). One milliliter of cells was pelleted
and suspended in an equal volume of Z-buﬀer (0.06 M
Na2HPO4, 0.04 M NaH2PO4, 0.01 M KCl, 1 mM
MgSO4, 0.05 M b-mercaptoethanol pH 7.0). The
OD600nm was again determined for use in calculations
and cells were sonicated (10 one s pulses, using a micro-
probe). Eight hundred microliters of lysate and 200 ll of
Z-buﬀer were mixed and equilibrated at 28 C for 5 min.
Two hundred microliters of ONPG substrate (4 mg/ml
o-nitrophenyl-b-D-galactopyranoside in 0.1 M sodium
phosphate buﬀer pH 7.0) was added and incubated at
28 C for 15 min followed by addition of 0.5 ml of
1 M Na2C03 to stop the reaction. Cell debris was re-
moved by centrifugation and absorbance measured at
420 and 550 nm. Enzyme activity in Miller units was cal-
culated using standard methods.
2.5. Antibody production
Polyclonal antibodies were produced against the
RsaD protein using a GST-RsaD fusion protein. The
pGEX4T3: rsaD plasmid was expressed in E. coli
(DH5a), and the protein was only produced in the form
of inclusion bodies. Protein in inclusion bodies was iso-
lated by growing cells to an OD600 of 1, centrifuging
cells and suspending in 1 · PBS buﬀer, followed by addi-
tion of lysozyme (100 lg/ml) for 1 h at 25 C and then
additions of RNAseA (50 lg/ml) and DNAseI (1 lg/
ml) for an additional hour at 25 C. 10% SDS, SDS–
PAGE sample buﬀer and samples were mixed at a
1:1:1 ratio. Samples were boiled for 5 min and then
put on ice for 15 min and centrifuged at 16,000 · g for
10 min. The inclusion body pellet was recovered and dis-
solved in 4 M urea. The preparation was dialyzed
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dH2O changes to remove urea. A New Zealand white
rabbit was immunized with the recovered protein and
Freunds incomplete adjuvant; the rabbit serum was col-
lected and processed using standard protocols [15] and
the immunoglobulin fraction was enriched by treatment
of the serum with an equal amount of saturated ammo-
nium sulfate and subsequent dialysis of the globulin pre-
cipitate against phosphate buﬀered saline.
RsaE antibodies were made using a GST-RsaE fusion
protein. The pGEX4T3: rsaE plasmid was expressed in
E. coli JM109 and soluble protein was produced and
puriﬁed. JM109 cells with the pGEX4T3: rsaE plasmid
were grown to OD600  0.8 and then incubated with
0.1 mM IPTG at 30 C for 3 h. Cells were then pelleted
and resuspended in cold buﬀer (PBS/0.5% Tween-20/
1 M NaCl/10 mM DTT/1 mM PMSF). Resuspended
cells were sonicated and then centrifuged and the super-
natant was saved. The supernatant was added to gluta-
thione–Sepharose beads (Sigma) and mixed for 1 h.
After rocking, beads were centrifuged and the superna-
tant was aspirated. Beads were washed three times using
PBS. GST-tagged RsaE protein was eluted using 50 mM
Tris–HCl pH 8/10 mM reduced Glutathione (Sigma).
Eluted protein fractions were pooled and dialyzed
against dH2O. Dialyzed protein was then injected into
New Zealand white rabbit and antisera recovered as
above.
2.6. Protein techniques
S-layer protein from C. crescentus cells was extracted
by low pH extraction as previously described [22]. To
compare the amounts of surface layer protein extracted
from diﬀerent mutants, normalized levels of cells (deter-
mined by OD600) growing at log phase were used and
equal amounts of extracted protein samples were loaded
onto Sodium dodecyl sulfate (SDS)–poly-acrylamide gel
electrophoresis (PAGE) gels.
Whole cell protein preparations were done as above,
cultures were centrifuged and cell pellets washed twice
with 10 mM Tris–HCl pH 8. Pellets were resuspended
in 10 mM Tris–HCl pH 8; lysozyme (100 lg/ml) was
added and incubated at 25 C for 15 min, followed by
RNAseA (50 lg/ml) and DNAseI (1 lg/ml) and incuba-
tion at 37 C for 30 min. Equal amounts of whole cell
preparations were loaded onto protein gels.
SDS–PAGE was done using 7.5% or 12% (as indi-
cated) separating gels. Coomassie stained SDS–PAGE
gels and western immunoblotting were performed as
previously described [15]. Western blots were probed
with primary rabbit polyclonal antibodies, and antibody
binding was visualized by either horseradish peroxidase
colorimetric [10] or chemiluminescence developing
methods. Chemiluminescent blotting was done using
the Amersham Biosciences ECL western blotting kit inaccordance with the manufacturers protocol and
Kodak X-OMAT LS ﬁlm was used for visualization.
Primary anti-RsaA antibodies (anti-188–784) were made
against portions of the RsaA protein as described [6]
and used at 1/15,000 for colorimetric and 1/30,000 for
chemiluminescent western blotting. The primary anti-
bodies, anti-RsaD and anti-RsaE were diluted at
1/1000 and 1/7500 for colorimetric and 1/3000 and
1/10,000 for chemiluminescent western blotting,
respectively.3. Results and discussion
3.1. Absence of an rsaE promoter is predicted by genetic
methods
The rsaE gene is located 135 bp after the rsaD gene.
When initial studies were carried out [11] there were no
convenient tools to identify a possible promoter and
the regulation of this region was assumed to be analo-
gous to HlyA. Production of polyclonal antibodies
against RsaD and RsaE proteins allowed for indirect
determination of rsaE promoter activity. Using the pre-
viously created B15Tn5 rsaD knockout strain [11]
whole-cell protein samples of the B15 Tn5 rsaD and
wild type NA1000 strains were run on SDS–PAGE
gels, and western blots were probed with anti-RsaD
antibodies (Fig. 2(a)). As expected, the NA1000 strain
contained RsaD whereas no RsaD was present in
B15Tn5 rsaD. RsaD antiserum was generated using
protein from inclusion bodies resulting in high back-
ground activity to other Caulobacter proteins. There-
fore we generally used anti-RsaE for western analysis
because more deﬁnitive results could be obtained. Wes-
tern blots using anti-RsaE antibodies showed the ex-
pected presence of RsaE for NA1000 while
B15Tn5rsaD did not (Fig. 2(b)). If a promoter was lo-
cated in the intergenic space between rsaD and rsaE,
then presumably it would be active despite the Tn5
insertion. Since no rsaE product could be detected in
the rsaD Tn5 mutant, it is likely the rsaD and rsaE
genes are transcribed using the same promoter.
3.2. Prediction of an rsaD promoter
Possible promoters were identiﬁed in the 242 bp re-
gion between the stop codon of rsaA and the start codon
of rsaD using in-silico and manual scanning methods.
Scanning software (BPROM) predicted a promoter
140 bp 5 0 of rsaD (Fig. 1(a)) with a putative 35 site
(rsaD 35(1)) located 147–141 bp upstream from the
rsaD start codon. The putative 10 site is located
123–115 bp 5 0 of the rsaD start site. The ribosomal bind-
ing site was predicted to be in the region 11–7 bp 5 0 of
the start codon.
Fig. 1. In-silico predicted rsaD promoter orientation and binding sites: (a) prediction of the rsaD promoter using the Softberry BPROM program.
The sequence shown begins with the end of rsaA (indicated by dark shadowing) and concludes with the beginning of rsaD (medium shadow). The two
sequences for the predicted rho-independent terminator of rsaA are also indicated by medium shadow and the predicted ribosome binding region of
rsaD by underscore. Identiﬁed 10 and 35 sites are indicated as bold text 115 bp upstream of rsaD. Two possible 35 sites are shown since both
show similarity to consensus C. crescentus promoter sequences. The promoter site is located far enough away from the q-independent terminator to
allow for polymerase binding and (b) the predicted rsaD promoter sequences compared to consensus promoter sequences. Both 35 sites are similar
to the consensus site, but the rsaD 35 (2) appears a better ﬁt since the consensus TTG bases are identical.
Fig. 2. Characterization of CB15A B15: (a) colorimetric western blot of whole culture preparations using: anti-RsaD. Lane 1, CB15A B15 (rsaD),
Lane 2, NA1000 wild type, demonstrating RsaD expression (arrow) and (b) colorimetric western blot of whole culture preparations using anti-RsaE.
Lane 1, CB15A B15 (rsaD) demonstrating loss of RsaE, Lane 2, NA1000 wild type.
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ser to the 10 site after analysis of the intergenic space
using the previously predicted consensus C. crescentus
promoter sequence [23]. The rsaD 35(1) site lies 19
bp away from the 10 site, whereas the rsaD 35(2) site
is only 10 bp from the 10 site. Of the two predicted
35 sites, the latter 35(2) site makes the spacing of
the predicted (35,10) binding sites similar to those
identiﬁed for promoters in C. crescentus. As well, the
rsaD 35(2) site has a better ﬁt with the consensus
35 site as the TTG bases are highly conserved in Cau-
lobacter with the second T being conserved for all iden-
tiﬁed promoter sites (Fig. 1(b)). Although BPROMclaims 80% accuracy in promoter identiﬁcation, this is
based on the E. coli sigma 70 promoters and may not re-
late directly to C. crescentus. We therefore suggest that
the architecture of the promoter region consists of the
rsaD 35(2) site and the predicted 10 site. These
results support the later molecular based ﬁndings
described below.
In addition, the 135 bp region separating rsaD and
rsaE was also analyzed to determine if there was a po-
tential promoter. BPROM identiﬁed no promoters in
the region, and no sites show signiﬁcant similarity to
predicted C. crescentus promoter sequences, conﬁrming
the western results.
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methods
A chromosomal deletion removing the region starting
242 bp 5 0 of the translational start site of rsaA to 8 bp 5 0
of the rsaA translational stop codon was constructed in
CB15 (strain UJ2602). Loss of rsaA was conﬁrmed by
PCR (not shown) and western immunoblotting using
the anti-RsaA antibodies demonstrated that no RsaA
was produced (Fig. 3(a)). In this mutant, the entire rsaA
promoter and gene have been removed while retaining
the putative rsaA transcription terminator. Also, the
promoter immediately upstream of rsaA is transcribed
in the opposite direction [13], so there was little possibil-
ity of read-through causing transcription of rsaD and
rsaE. Western blots show that both the wild-type
NA1000 and UJ2602 strain produce RsaD (data not
shown) and RsaE (Fig. 3(b)). To conﬁrm that these
transporter proteins were active in UJ2602, a plasmid
borne copy of rsaA was expressed in UJ2602 and secre-
tion of S-layer was evident in the complemented strainFig. 3. Characterization of CB15 UJ2602: (a) chemiluminescent western b
NA1000, demonstrating wild type RsaA expression. Lane 2, UJ2602, demo
chemiluminescent western blot of whole culture preparations using anti-Rsa
UJ2602 demonstrating presence of RsaE. Lane 3, NA1000 wild type, demons
activity at 60–65 kDa is a non-speciﬁc binding activity characteristic of
colorimetric western of low pH extracted protein using anti-188/784 RsaA. L
rsaA, indicating restoration of RsaA secretion. Lane 3, NA1000 demonstrat(Fig. 3(c)). The level of RsaA secretion was comparable
to wild-type, suggesting that production of RsaD and
RsaE was not aﬀected by the loss of the chromosomal
copy of rsaA and its promoter.
To conﬁrm that a putative rsaDE promoter was actu-
ally driving transcription of rsaD and rsaE, a second
molecular method was undertaken. Strain B15Tn5rsaD
showed no secretion of RsaA since it lacks a functional
copy of rsaD [11] (see Fig. 2). A strategy using trans-
complementation of a plasmid borne copy of rsaADE
was adopted to determine transcriptional control. The
plasmid-borne RAT1 genome fragment [11], which in-
cludes rsaADE as well as ﬂanking regions (total length
11 kb) was modiﬁed so that its copy of rsaA was
knocked out using the XCm antibiotic resistance cas-
sette which contains transcription terminators at both
ends. This presumably eliminates transcription read-
through from the rsaA promoter on the plasmid vector.
Western blots of low pH extracted protein showed that
the B15Tn5rsaD mutant containing the modiﬁed RAT1
fragment secreted RsaA (Fig. 4(a)). This indicated thelot of whole culture preparations using anti-188/784 RsaA. Lane 1,
nstrating the absence of RsaA. RsaA position marked by arrow; (b)
E. Lane 1, CB15A Tn5 mutant B15 shows absence of RsaE. Lane 2,
trating RsaE expression. RsaE position is marked with arrow. Binding
this antisera (it is also seen, but to a lesser extent in Fig. 2) and (c)
ane 1, UJ2602 demonstrating the loss of RsaA. Lane 2 UJ2602: pWB9:
es wild type RsaA secretion levels. RsaA position marked by arrow.
Fig. 4. Characterization of CB15A B15: RAT1XCm: (a) chemiluminescent western blot of whole culture preparations using anti-188/784 RsaA.
Lane 1, NA1000 wild type. Lane 2, CB15A B15 (rsaD) indicating a loss of RsaA production. Lane 3, CB15A B15: RAT1XCm, indicating
restoration of RsaA secretion; (b) chemiluminescent western blot of whole cell preparation using anti-RsaE. Lane 1, CB15A B15: RAT1XCm,
indicating restoration of RsaE expression. Lane 2, CB15A B15 strain (rsaD)) demonstrates the loss of RsaE. Lane 3, NA1000, wild type levels of
RsaE.
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allow RsaA secretion. Western blots conﬁrmed that
both RsaD (not shown) and RsaE (Fig. 4(b)) were pres-
ent in the complemented strain.
3.4. Direct assessment of promoter activity
As an additional conﬁrmation of promoter activity
the regions adjacent to predicted expressed proteins
from rsaD and rsaE were cloned and assessed using a
b-galactosidase reporter vector. For the region 5 0 of
rsaD 983 (±107) relative (Miller) units of activity were
recorded, compared to 57 (±24) units for the rsaE 5 0 re-
gion and 9 (±0.6) units for the null plasmid control.
Thus signiﬁcant transcription activity for rsaD was ob-
tained while activity for rsaE, though above back-
ground, was judged as negligible.
Taken together, the results indicate that the rsaD and
rsaE genes must be transcribed using a promoter just
downstream of rsaA, presumably after the putative rsaA
rho-independent terminator.
Thus, the rsaA promoter was not involved in the
transcription of the downstream transporter compo-
nents rsaD and rsaE and so may explain why previous
unsuccessful attempts to express the rsaA, D and E
genes in E. coli were not due to improper antitermina-
tion of the rho-independent terminator as suggested
[24], but are more likely due to E. coli not recognizing
the newly found rsaDE promoter.
We propose that in C. crescentus, the rsaD and rsaE
genes are transcribed separately from the rsaA gene in
order to produce a larger amount of transporter units
to enable high levels of protein secretion. If transcription
of the rsaD and rsaE genes relied on leakiness of the rho
independent terminator, it is possible that not enough
copies of the transport apparatus would be produced.
The amount of protein secreted by the E. coli HlyA sys-
tem (where presumably transcriptional leakiness in the
HlyA system allows adequate levels of secretion) is
0.5–2% of the total cell protein where as the S-layer of
C. crescentus accounts for 10–12% of the total cell pro-
tein. Determining transcription of the RsaA transportcomponents may aid in further increasing levels of S-
layer secretion.Acknowledgement
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